{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:08:01Z","timestamp":1793390881278,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00259-019-04517-y","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:03:31Z","timestamp":1568066611000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort"],"prefix":"10.1007","volume":"47","author":[{"given":"Arighno","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samdeep","family":"Mouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-1825","authenticated-orcid":false,"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"4517_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"DM Parkin","year":"2001","unstructured":"Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533\u201343. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(01)00486-7\n\n.","journal-title":"Lancet Oncol"},{"key":"4517_CR2","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u201376. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2007.04.061\n\n.","journal-title":"Gastroenterology."},{"issue":"Suppl","key":"4517_CR3","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","volume":"47","author":"S Mittal","year":"2013","unstructured":"Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47(Suppl):S2\u20136. \nhttps:\/\/doi.org\/10.1097\/MCG.0b013e3182872f29\n\n.","journal-title":"J Clin Gastroenterol"},{"key":"4517_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.sla.0000086548.84705.ef","volume":"238","author":"CH Cha","year":"2003","unstructured":"Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238:315\u201321; discussion 21-3. \nhttps:\/\/doi.org\/10.1097\/01.sla.0000086548.84705.ef\n\n.","journal-title":"Ann Surg"},{"key":"4517_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","volume":"138","author":"R Salem","year":"2010","unstructured":"Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010;138:52\u201364. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2009.09.006\n\n.","journal-title":"Gastroenterology."},{"key":"4517_CR6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2214\/ajr.162.6.8191985","volume":"162","author":"M Lin","year":"1994","unstructured":"Lin M. Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings. AJR Am J Roentgenol. 1994;162:1300\u20132.","journal-title":"AJR Am J Roentgenol"},{"key":"4517_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/hep.29207","volume":"66","author":"B Sangro","year":"2017","unstructured":"Sangro B, Martinez-Urbistondo D, Bester L, Bilbao JI, Coldwell DM, Flamen P, et al. Prevention and treatment of complications of selective internal radiation therapy: expert guidance and systematic review. Hepatology. 2017;66:969\u201382. \nhttps:\/\/doi.org\/10.1002\/hep.29207\n\n.","journal-title":"Hepatology."},{"key":"4517_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jvir.2012.01.059","volume":"23","author":"CL Wright","year":"2012","unstructured":"Wright CL, Werner JD, Tran JM, Gates VL, Rikabi AA, Shah MH, et al. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review. J Vasc Interv Radiol. 2012;23:669\u201374. \nhttps:\/\/doi.org\/10.1016\/j.jvir.2012.01.059\n\n.","journal-title":"J Vasc Interv Radiol"},{"key":"4517_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0360-3016(95)00039-3","volume":"33","author":"TW Leung","year":"1995","unstructured":"Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR10","first-page":"293","volume":"24","author":"S Ho","year":"1997","unstructured":"Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med. 1997;24:293\u20138.","journal-title":"Eur J Nucl Med"},{"key":"4517_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","volume":"31","author":"R Salem","year":"2008","unstructured":"Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31:431\u20138. \nhttps:\/\/doi.org\/10.1097\/COC.0b013e318168ef65\n\n.","journal-title":"Am J Clin Oncol"},{"key":"4517_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251\u201378. \nhttps:\/\/doi.org\/10.1097\/01.RVI.0000233785.75257.9A\n\n.","journal-title":"J Vasc Interv Radiol"},{"key":"4517_CR13","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol. 2006;17:1425\u201339. \nhttps:\/\/doi.org\/10.1097\/01.RVI.0000235779.88652.53\n\n.","journal-title":"J Vasc Interv Radiol"},{"key":"4517_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jhep.2014.03.023","volume":"61","author":"L Kulik","year":"2014","unstructured":"Kulik L, Vouche M, Koppe S, Lewandowski RJ, Mulcahy MF, Ganger D, et al. Prospective randomized pilot study of Y90+\/\u2212sorafenib as bridge to transplantation in hepatocellular carcinoma. J Hepatol. 2014;61:309\u201317. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2014.03.023\n\n.","journal-title":"J Hepatol"},{"key":"4517_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"4517_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jhep.2010.10.004","volume":"54","author":"A Riaz","year":"2011","unstructured":"Riaz A, Memon K, Miller FH, Nikolaidis P, Kulik LM, Lewandowski RJ, et al. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol. 2011;54:695\u2013704. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2010.10.004\n\n.","journal-title":"J Hepatol"},{"key":"4517_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/RLU.0000000000000915","volume":"41","author":"M Xing","year":"2016","unstructured":"Xing M, Lahti S, Kokabi N, Schuster DM, Camacho JC, Kim HS. 90Y radioembolization lung shunt fraction in primary and metastatic liver cancer as a biomarker for survival. Clin Nucl Med. 2016;41:21\u20137. \nhttps:\/\/doi.org\/10.1097\/RLU.0000000000000915\n\n.","journal-title":"Clin Nucl Med"},{"key":"4517_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00270-016-1323-4","volume":"39","author":"JM Ludwig","year":"2016","unstructured":"Ludwig JM, Ambinder EM, Ghodadra A, Xing M, Prajapati HJ, Kim HS. Lung shunt fraction prior to yttrium-90 radioembolization predicts survival in patients with neuroendocrine liver metastases: single-center prospective analysis. Cardiovasc Intervent Radiol. 2016;39:1007\u201314. \nhttps:\/\/doi.org\/10.1007\/s00270-016-1323-4\n\n.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4517_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/s1470-2045(18)30937-9","volume":"20","author":"AX Zhu","year":"2019","unstructured":"Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, et al. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019;20:282\u201396. \nhttps:\/\/doi.org\/10.1016\/s1470-2045(18)30937-9\n\n.","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04517-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T05:38:36Z","timestamp":1599716316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04517-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4517"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04517-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AR, RL, and RS are advisors to BTG. None of the other authors have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by our institutional review board and the requirement to obtain informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}